| Description | FGF5 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components FGF5 siRNA-1: 5 nmol (HPLC) FGF5 siRNA-2: 5 nmol (HPLC) FGF5 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 FGF5 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components FGF5 siRNA-1: 5 nmol (HPLC) FGF5 siRNA-2: 5 nmol (HPLC) FGF5 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Dezamizumab (anti-Serum Amyloid P) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab (anti-Serum Amyloid P) triggers immunotherapeutic clearance of amyloid. Dezamizumab (anti-Serum Amyloid P) can be used Dezamizumab (anti-Serum Amyloid P) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab (anti-Serum Amyloid P) triggers immunotherapeutic clearance of amyloid. Dezamizumab (anti-Serum Amyloid P) can be used in research of Amyloid light-chain (AL) amyloidosis... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Inquire | Telomerase-IN-3 is a telomerase inhibitor, which directly targets hTERT promoter activity. hTERT is the key component for maintenance of telomerase activity.Form:Solid |